Guidance

Impact assessment to permit a 0.2 percent increase in the list price of branded medicines supplied by manufactures and suppliers under the statutory scheme from January 2012

Impact assessment to permit a 0.2 percent increase in the list price of branded medicines supplied by manufactures and suppliers under the statutory scheme from January 2012.

From:
Department of Health and Social Care
Published
7 December 2011

Documents

Download Impact Assessment - increase in branded medicine

PDF, 1.01 MB, 16 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Impact assessment to permit a 0.2 percent increase in the list price of branded medicines supplied by manufactures and suppliers under the statutory scheme from January 2012.

Published 7 December 2011